phosphatidylcholines has been researched along with Hemorrhagic Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gorina, E; Harrison, JA; Luk, A; Nugent, DJ; Powell, JS; Soni, A; Stass, H | 1 |
Carter, CJ; Chonn, A; Devine, DV; Krikler, SH; Levitt, D | 1 |
1 trial(s) available for phosphatidylcholines and Hemorrhagic Disorders
Article | Year |
---|---|
Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A.
Topics: Adolescent; Adult; Biological Availability; Cholesterol; Cholesterol, LDL; Complement C3a; Complement Hemolytic Activity Assay; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Factor VIII; Half-Life; Hemophilia A; Hemorrhagic Disorders; Humans; Infusions, Intravenous; Liposomes; Male; Metabolic Clearance Rate; Middle Aged; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Recombinant Proteins | 2008 |
1 other study(ies) available for phosphatidylcholines and Hemorrhagic Disorders
Article | Year |
---|---|
Fatal bleeding in a patient with a non-specific PT and APTT inhibitor.
Topics: Aged; Aged, 80 and over; Antiphospholipid Syndrome; Autoimmune Diseases; Blood Coagulation Factors; Blood Platelets; Female; Hemorrhagic Disorders; Humans; Immunoglobulin G; Immunoglobulin lambda-Chains; Liposomes; Lupus Coagulation Inhibitor; Paraproteinemias; Partial Thromboplastin Time; Phosphatidylcholines; Prothrombin; Prothrombin Time | 1992 |